Karyotypic and molecular abnormalities in chronic lymphocytic leukaemia

af Fegan, C D, Davies, F E
Udgivet 1996

Evolving treatment strategies for myeloma

af Morgan, G J, Davies, F E
Udgivet 2005

Reply to letters on review ‘Evolving treatment strategies for myeloma’

af Morgan, G J, Davies, F E
Udgivet 2005

Understanding the interplay between the proteasome pathway and autophagy in response to dual PI3K/mTOR inhibition in myeloma cells is essential for their effective clinical applica...

af Aronson, L I, Davenport, E L, Mirabella, F, Morgan, G J, Davies, F E
Udgivet 2013

Assessing response of myeloma bone disease with diffusion-weighted MRI

af Messiou, C, Giles, S, Collins, D J, West, S, Davies, F E, Morgan, G J, Desouza, N M
Udgivet 2012

Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease bur...

af Giles, S.L., deSouza, N.M., Collins, D.J., Morgan, V.A., West, S., Davies, F.E., Morgan, G.J., Messiou, C.
Udgivet i Clin Radiol (2015)

Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?

af Pawlyn, C, Fowkes, L, Otero, S, Jones, J R, Boyd, K D, Davies, F E, Morgan, G J, Collins, D J, Sharma, B, Riddell, A, Kaiser, M F, Messiou, C
Udgivet i Leukemia (2016)

Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients

af Walker, B A, Wardell, C P, Brioli, A, Boyle, E, Kaiser, M F, Begum, D B, Dahir, N B, Johnson, D C, Ross, F M, Davies, F E, Morgan, G J
Udgivet 2014

Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

af Dimopoulos, M A, Leleu, X, Palumbo, A, Moreau, P, Delforge, M, Cavo, M, Ludwig, H, Morgan, G J, Davies, F E, Sonneveld, P, Schey, S A, Zweegman, S, Hansson, M, Weisel, K, Mateos, M V, Facon, T, Miguel, J F S
Udgivet 2014

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control

af Pawlyn, C, Bright, M D, Buros, A F, Stein, C K, Walters, Z, Aronson, L I, Mirabella, F, Jones, J R, Kaiser, M F, Walker, B A, Jackson, G H, Clarke, P A, Bergsagel, P L, Workman, P, Chesi, M, Morgan, G J, Davies, F E
Udgivet i Blood Cancer J (2017)

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

af Rasche, L., Chavan, S. S., Stephens, O. W., Patel, P. H., Tytarenko, R., Ashby, C., Bauer, M., Stein, C., Deshpande, S., Wardell, C., Buzder, T., Molnar, G., Zangari, M., van Rhee, F., Thanendrarajan, S., Schinke, C., Epstein, J., Davies, F. E., Walker, B. A., Meissner, T., Barlogie, B., Morgan, G. J., Weinhold, N.
Udgivet i Nat Commun (2017)

Combination of Flow Cytometry and Functional Imaging for Monitoring of Residual Disease in Myeloma

af Rasche, L, Alapat, D, Kumar, M, Gershner, G, McDonald, J, Wardell, C.P, Samant, R, Van Hemert, R, Epstein, J, Williams, A.F, Thanendrarajan, S, Schinke, C, Bauer, M, Ashby, C, Tytarenko, R.G, van Rhee, F, Walker, B.A, Zangari, M, Barlogie, B, Davies, F.E, Morgan, G.J, Weinhold, N
Udgivet i Leukemia (2018)

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial

af Jones, J R, Cairns, D A, Gregory, W M, Collett, C, Pawlyn, C, Sigsworth, R, Striha, A, Henderson, R, Kaiser, M F, Jenner, M, Cook, G, Russell, N H, Williams, C, Pratt, G, Kishore, B, Lindsay, J, Drayson, M T, Davies, F E, Boyd, K D, Owen, R G, Jackson, G H, Morgan, G J
Udgivet i Blood Cancer J (2016)

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

af Chavan, S S, He, J, Tytarenko, R, Deshpande, S, Patel, P, Bailey, M, Stein, C K, Stephens, O, Weinhold, N, Petty, N, Steward, D, Rasche, L, Bauer, M, Ashby, C, Peterson, E, Ali, S, Ross, J, Miller, V A, Stephens, P, Thanendrarajan, S, Schinke, C, Zangari, M, van Rhee, F, Barlogie, B, Mughal, T I, Davies, F E, Morgan, G J, Walker, B A
Udgivet i Blood Cancer J (2017)

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients

af Shah, V, Sherborne, A L, Walker, B A, Johnson, D C, Boyle, E M, Ellis, S, Begum, D B, Proszek, P Z, Jones, J R, Pawlyn, C, Savola, S, Jenner, M W, Drayson, M T, Owen, R G, Houlston, R S, Cairns, D A, Gregory, W M, Cook, G, Davies, F E, Jackson, G H, Morgan, G J, Kaiser, M F
Udgivet i Leukemia (2018)

Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach

af Went, M, Sud, A, Law, P J, Johnson, D C, Weinhold, N, Försti, A, van Duin, M, Mitchell, J S, Chen, B, Kuiper, R, Stephens, O W, Bertsch, U, Campo, C, Einsele, H, Gregory, W M, Henrion, M, Hillengass, J, Hoffmann, P, Jackson, G H, Lenive, O, Nickel, J, Nöthen, M M, da Silva Filho, M I, Thomsen, H, Walker, B A, Broyl, A, Davies, F E, Langer, C, Hansson, M, Kaiser, M, Sonneveld, P, Goldschmidt, H, Hemminki, K, Nilsson, B, Morgan, G J, Houlston, R S
Udgivet i Blood Cancer J (2017)